×
For best experience we recommend to activate Javascript in your browser.
RARRES1 antibody (AA 43-294)
This anti-RARRES1 antibody is a Rabbit Polyclonal antibody detecting RARRES1 in WB, IHC, IP and ICC. Suitable for Human.
Quick Overview for RARRES1 antibody (AA 43-294) (ABIN7626204)
Target
See all RARRES1 Antibodies
RARRES1
(Retinoic Acid Receptor Responder (Tazarotene Induced) 1 (RARRES1))
Reactivity
All reactivities for RARRES1 antibodies
Human
Host
All hosts for RARRES1 antibodies
Rabbit
Clonality
All clonalities for RARRES1 antibodies
Polyclonal
Conjugate
All conjugates for RARRES1 antibodies
This RARRES1 antibody is un-conjugated
Application
All applications for RARRES1 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-RARRES1 Antibody
(hide)
Binding Specificity
All epitopes for RARRES1 antibodies
AA 43-294
Purpose
Retinoic Acid Receptor Responder 1 (RARRES1) Polyclonal Antibody
Sequence
Pro43~Phe294
Characteristics
The Retinoic Acid Receptor Responder 1 (RARRES1) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for RARRES1
(hide)
Target
RARRES1
(Retinoic Acid Receptor Responder (Tazarotene Induced) 1 (RARRES1))
Alternative Name
RARRES1
Gene ID
5918
UniProt
P49788
Recently viewed
(hide)
Chat with us , powered by LiveChat